Trial site
New England Cancer Specialists
- 9running trials
- 6closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Metastatic breast cancer4 trials
- Chronic lymphocytic leukaemia2 trials
- Prostate cancer2 trials
- Triple-negative breast cancer2 trials
- Kidney cancer1 trial
- Phase
- Phase 311 trials
- Phase 24 trials
- Status
- Active, not recruiting5 trials
- Completed5 trials
- Recruiting4 trials
- Terminated1 trial
- Lead sponsor
- Hoffmann-La Roche3 trials
- Alliance Foundation Trials, LLC.2 trials
- Dana-Farber Cancer Institute1 trial
- G1 Therapeutics, Inc.1 trial
- Genentech, Inc.1 trial
- and 7 more
Running trials
Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Recruiting
Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic lymphocytic leukaemia2 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Terminated
Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer
Completed
Completed
Completed
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
Completed
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
Site data: ClinicalTrials.govUpdated 12 Nov 2026